Skip to main content
SpringerLink
Log in

Dissection of Complex Genetic and Epigenetic Interactions Underlying NF1 Cancer Susceptibility Using Mouse Models

  • Chapter
  • First Online:
Neurofibromatosis Type 1

  • 1514 Accesses

Abstract

NF1 is notable for the variable expressivity of the disease. Although NF1 is fully penetrant, patients with the disease show a broad range of phenotypes. This presents a problem for patients and their doctors, because it is difficult to predict which disease complications an individual will develop. This has led to an interest in identifying the sources of phenotypic variation associated with the disease. Inherited factors, environmental factors, and diet can all influence phenotypic variation and differential susceptibility in many diseases, including NF1. Comparison of both inter- and intra-familial phenotypic variance in patients has implicated heritable factors independent of the inherited NF1 allele, as well as environmental factors. Studies in a mouse model of NF1 malignancies have demonstrated that modifier genes unlinked to NF1, as well as the sex of the individual and the inheritance of the disease from the mother or father, affects the risk for developing different types of tumors. Taken together, these data suggest that subtle differences in the genetic and epigenetic background of NF1 patients can have far reaching implications on the risk of developing NF1-associated tumors. In this chapter, we will focus on what is known about heritable factors affecting NF1 variable expressivity in both humans and mouse models. These factors, once characterized, can be used by patients and clinicians to predict the future course of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Airewele GE, Sigurdson AJ, Wiley KJ, Frieden BE, Caldarera LW, Riccardi VM, Lewis RA, Chintagumpala MM, Ater JL, Plon SE, Bondy ML (2001) Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer. Genet Epidemiol 20:75–86

    Article  PubMed  CAS  Google Scholar 

  • Amlin-Van Schaick J, Kim S, Broman KW, Reilly KM (2012a) Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5. Mamm Genome 23:277–285

    Article  PubMed  CAS  Google Scholar 

  • Amlin-Van Schaick JC, Kim S, DiFabio C, Lee MH, Broman KW, Reilly KM (2012b) Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12. Neuro Oncol 14:160–174

    Article  PubMed  CAS  Google Scholar 

  • Amlin-Van Schaick J, Kim S, Broman KW, Reilly KM (2012c) Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5. Mamm Genome 23(3–4):277–85

    Article  PubMed  CAS  Google Scholar 

  • Aylor DL, Valdar W, Foulds-Mathes W, Buus RJ, Verdugo RA, Baric RS, Ferris MT, Frelinger JA, Heise M, Frieman MB et al (2012) Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Res 21:1213–1222

    Article  Google Scholar 

  • Bahuau M, Pelet A, Vidaud D, Lamireau T, LeBail B, Munnich A, Vidaud M, Lyonnet S, Lacombe D (2001) GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype. J Med Genet 38:638–643

    Article  PubMed  CAS  Google Scholar 

  • Bajenaru ML, Hernandez MR, Perry A, Zhu Y, Parada LF, Garbow JR, Gutmann DH (2003) Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res 63:8573–8577

    PubMed  CAS  Google Scholar 

  • Barron VA, Lou H (2012) Alternative splicing of the neurofibromatosis type I pre-mRNA. Biosci Rep 32:131–138

    Article  PubMed  CAS  Google Scholar 

  • Bartelt-Kirbach B, Wuepping M, Dodrimont-Lattke M, Kaufmann D (2009) Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation. Neurogenetics 10:79–85

    Article  PubMed  CAS  Google Scholar 

  • Buchberg AM, Buckwalter MS, Camper SA (1992) Mouse chromosome 11. Mamm Genome 3(Spec No):S162–S181

    Google Scholar 

  • Carey JC, Laub JM, Hall BD (1979) Penetrance and variability in neurofibromatosis: a genetic study of 60 families. Birth Defects Orig Artic Ser 15:271–281

    PubMed  CAS  Google Scholar 

  • Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W et al (2004) The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 36:1133–1137

    Article  PubMed  CAS  Google Scholar 

  • Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME, Bronson RT, Jacks T (1999) Mouse models of tumor development in neurofibromatosis type 1. Science 286:2172–2176

    Article  PubMed  CAS  Google Scholar 

  • Collaborative Cross Consortium (2012) The genome architecture of the Collaborative Cross mouse genetic reference population. Genetics 190:389–401

    Article  Google Scholar 

  • Durrant C, Tayem H, Yalcin B, Cleak J, Goodstadt L, de Villena FP, Mott R, Iraqi FA (2011) Collaborative Cross mice and their power to map host susceptibility to Aspergillus fumigatus infection. Genome Res 21:1239–1248

    Article  PubMed  CAS  Google Scholar 

  • Easton DF, Ponder MA, Huson SM, Ponder BA (1993) An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53:305–313

    PubMed  CAS  Google Scholar 

  • Evans DG, O’Hara C, Wilding A, Ingham SL, Howard E, Dawson J, Moran A, Scott-Kitching V, Holt F, Huson SM (2011) Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19:1187–1191

    Article  PubMed  Google Scholar 

  • Harder A, Titze S, Herbst L, Harder T, Guse K, Tinschert S, Kaufmann D, Rosenbaum T, Mautner VF, Windt E et al (2010) Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5′ untranslated region, exon and intron 1. Twin Res Hum Genet 13:582–594

    Article  PubMed  Google Scholar 

  • Hawes JJ, Tuskan RG, Reilly KM (2007) Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics 8:121–130

    Article  PubMed  CAS  Google Scholar 

  • Huson SM, Hughes RAC (1994) The neurofibromatoses: a pathogenetic and clinical overview, 1st edn. Chapman & Hall Medical, London

    Google Scholar 

  • Ingham S, Huson SM, Moran A, Wylie J, Leahy M, Evans DG (2011) Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years. Eur J Cancer 47:2723–2728

    Article  PubMed  Google Scholar 

  • Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7:353–361

    Article  PubMed  CAS  Google Scholar 

  • Jentarra GM, Rice SG, Olfers S, Rajan C, Saffen DM, Narayanan V (2012) Skewed allele-specific expression of the NF1 gene in normal subjects: a possible mechanism for phenotypic variability in neurofibromatosis type 1. J Child Neurol 27:695–702

    Google Scholar 

  • Jhanwar SC, Chen Q, Li FP, Brennan MF, Woodruff JM (1994) Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet 78:138–144

    Article  PubMed  CAS  Google Scholar 

  • Kehrer-Sawatzki H, Schmid E, Funsterer C, Kluwe L, Mautner VF (2008) Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region. Am J Med Genet A 146A:691–699

    Article  PubMed  CAS  Google Scholar 

  • Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255–268

    Article  PubMed  CAS  Google Scholar 

  • Lazaro C, Gaona A, Ainsworth P, Tenconi R, Vidaud D, Kruyer H, Ars E, Volpini V, Estivill X (1996) Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet 98:696–699

    Article  PubMed  CAS  Google Scholar 

  • Li H, Zhang X, Fishbein L, Kweh F, Campbell-Thompson M, Perrin GQ, Muir D, Wallace M (2010) Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells. Cancer Biol Ther 10:758–764

    Article  PubMed  CAS  Google Scholar 

  • Masocco M, Kodra Y, Vichi M, Conti S, Kanieff M, Pace M, Frova L, Taruscio D (2011) Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006). Orphanet J Rare Dis 6:11

    Article  PubMed  Google Scholar 

  • Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP et al (1990) Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87:5435–5439

    Article  PubMed  CAS  Google Scholar 

  • Mensink KA, Ketterling RP, Flynn HC, Knudson RA, Lindor NM, Heese BA, Spinner RJ, Babovic-Vuksanovic D (2006) Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature. J Med Genet 43:e8

    Article  PubMed  CAS  Google Scholar 

  • Mertens F, Rydholm A, Bauer HF, Limon J, Nedoszytko B, Szadowska A, Willen H, Heim S, Mitelman F, Mandahl N (1995) Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer 61:793–798

    Article  PubMed  CAS  Google Scholar 

  • Mertens F, Dal Cin P, De Wever I, Fletcher CD, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G et al (2000) Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 190:31–38

    Article  PubMed  CAS  Google Scholar 

  • Pasmant E, Sabbagh A, Masliah-Planchon J, Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K, Valeyrie-Allanore L et al (2011) Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J Natl Cancer Inst 103:1713–1722

    Article  PubMed  CAS  Google Scholar 

  • Philip VM, Sokoloff G, Ackert-Bicknell CL, Striz M, Branstetter L, Beckmann MA, Spence JS, Jackson BL, Galloway LD, Barker P et al (2011) Genetic analysis in the Collaborative Cross breeding population. Genome Res 21:1223–1238

    Article  PubMed  CAS  Google Scholar 

  • Rasmussen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68:1110–1118

    Article  PubMed  CAS  Google Scholar 

  • Reilly KM (2009) Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk. Brain Pathol 19:121–131

    Article  PubMed  Google Scholar 

  • Reilly KM (2010) The Nf1−/+;Trp53−/+cis mouse model of anaplastic astrocytoma and secondary glioblastoma: dissecting genetic susceptibility to brain cancer. In: Van Meir EG (ed) CNS cancer: models, markers, prognostic factors, targets, and therapeutic approaches. Springer, Berlin

    Google Scholar 

  • Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T (2000) Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet 26:109–113

    Article  PubMed  CAS  Google Scholar 

  • Reilly KM, Tuskan RG, Christy E, Loisel DA, Ledger J, Bronson RT, Smith CD, Tsang S, Munroe DJ, Jacks T (2004) Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci USA 101:13008–13013

    Article  PubMed  CAS  Google Scholar 

  • Reilly KM, Broman KW, Bronson RT, Tsang S, Loisel DA, Christy ES, Sun Z, Diehl J, Munroe DJ, Tuskan RG (2006) An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model. Cancer Res 66:62–68

    Article  PubMed  CAS  Google Scholar 

  • Rey JA, Bello MJ, Kusak ME, de Campos JM, Pestana A (1993) Involvement of 22q12 in a neurofibrosarcoma in neurofibromatosis type 1. Cancer Genet Cytogenet 66:28–32

    Article  PubMed  CAS  Google Scholar 

  • Riva P, Corrado L, Natacci F, Castorina P, Wu BL, Schneider GH, Clementi M, Tenconi R, Korf BR, Larizza L (2000) NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet 66:100–109

    Article  PubMed  CAS  Google Scholar 

  • Sabbagh A, Pasmant E, Laurendeau I, Parfait B, Barbarot S, Guillot B, Combemale P, Ferkal S, Vidaud M, Aubourg P et al (2009) Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet 18:2768–2778

    Article  PubMed  CAS  Google Scholar 

  • Schmidt H, Taubert H, Wurl P, Bache M, Bartel F, Holzhausen HJ, Hinze R (2001) Cytogenetic characterization of six malignant peripheral nerve sheath tumors: comparison of karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet 128:14–23

    Article  PubMed  CAS  Google Scholar 

  • Skuse GR, Cappione AJ (1997) RNA processing and clinical variability in neurofibromatosis type I (NF1). Hum Mol Genet 6:1707–1712

    Article  PubMed  CAS  Google Scholar 

  • Spiegel M, Oexle K, Horn D, Windt E, Buske A, Albrecht B, Prott EC, Seemanova E, Seidel J, Rosenbaum T et al (2005) Childhood overgrowth in patients with common NF1 microdeletions. Eur J Hum Genet 13:883–888

    Article  PubMed  CAS  Google Scholar 

  • Steinmann K, Cooper DN, Kluwe L, Chuzhanova NA, Senger C, Serra E, Lazaro C, Gilaberte M, Wimmer K, Mautner VF, Kehrer-Sawatzki H (2007) Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination. Am J Hum Genet 81:1201–1220

    Article  PubMed  CAS  Google Scholar 

  • Stephens K, Weaver M, Leppig KA, Maruyama K, Emanuel PD, Le Beau MM, Shannon KM (2006) Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood 108:1684–1689

    Article  PubMed  CAS  Google Scholar 

  • Szudek J, Joe H, Friedman JM (2002) Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1). Genet Epidemiol 23:150–164

    Article  PubMed  CAS  Google Scholar 

  • Szudek J, Evans DG, Friedman JM (2003) Patterns of associations of clinical features in neurofibromatosis 1 (NF1). Hum Genet 112:289–297

    PubMed  Google Scholar 

  • Threadgill DW, Churchill GA (2012a) Ten years of the Collaborative Cross. Genetics 190:291–294

    Article  PubMed  Google Scholar 

  • Threadgill DW, Churchill GA (2012b) Ten years of the collaborative cross. G3 (Bethesda) 2:153–156

    Google Scholar 

  • Threadgill DW, Hunter KW, Williams RW (2002) Genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort. Mamm Genome 13:175–178

    Article  PubMed  CAS  Google Scholar 

  • Tischler AS, Shih TS, Williams BO, Jacks T (1995) Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1. Endocr Pathol 6:323–335

    Article  PubMed  Google Scholar 

  • Titze S, Peters H, Wahrisch S, Harder T, Guse K, Buske A, Tinschert S, Harder A (2010) Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients. Eur J Hum Genet 18:81–87

    Article  PubMed  CAS  Google Scholar 

  • Tuskan RG, Tsang S, Sun Z, Baer J, Rozenblum E, Wu X, Munroe DJ, Reilly KM (2008) Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels. Epigenetics 3:43–50

    Article  PubMed  Google Scholar 

  • Upadhyaya M, Ruggieri M, Maynard J, Osborn M, Hartog C, Mudd S, Penttinen M, Cordeiro I, Ponder M, Ponder BA et al (1998) Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 102:591–597

    Article  PubMed  CAS  Google Scholar 

  • Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S et al (2007) An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 80:140–151

    Article  PubMed  CAS  Google Scholar 

  • van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG (1994) p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst 86:1011–1017

    Article  PubMed  CAS  Google Scholar 

  • Venturin M, Guarnieri P, Natacci F, Stabile M, Tenconi R, Clementi M, Hernandez C, Thompson P, Upadhyaya M, Larizza L, Riva P (2004) Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet 41:35–41

    Article  PubMed  CAS  Google Scholar 

  • Walrath JC, Fox K, Truffer E, Gregory Alvord W, Quinones OA, Reilly KM (2009) Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner. Mamm Genome 20:214–223

    Article  PubMed  CAS  Google Scholar 

  • Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H (1997) Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 3:523–530

    PubMed  CAS  Google Scholar 

  • Wiest V, Eisenbarth I, Schmegner C, Krone W, Assum G (2003) Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers. Hum Mutat 22:423–427

    Article  PubMed  CAS  Google Scholar 

  • Wu J, Williams JP, Rizvi TA, Kordich JJ, Witte D, Meijer D, Stemmer-Rachamimov AO, Cancelas JA, Ratner N (2008) Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 13:105–116

    Article  PubMed  CAS  Google Scholar 

  • Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296:920–922

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mouse Cancer Genetics Program, National Cancer Institute, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA

    Georgette N. Jones & Karlyne M. Reilly

Authors
  1. Georgette N. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karlyne M. Reilly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karlyne M. Reilly .

Editor information

Editors and Affiliations

  1. School of Medicine, Institute of Medical Genetics, Cardiff University, Heath Park Campus, Cardiff, 144XN, United Kingdom

    Meena Upadhyaya

  2. School of Medicine, Institute of Medical Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN, United Kingdom

    David N. Cooper

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jones, G.N., Reilly, K.M. (2012). Dissection of Complex Genetic and Epigenetic Interactions Underlying NF1 Cancer Susceptibility Using Mouse Models. In: Upadhyaya, M., Cooper, D. (eds) Neurofibromatosis Type 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-32864-0_19

Download citation

Publish with us

Policies and ethics

Search

Navigation